Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

48.56 -0.07 (-0.14%)

Streaming Delayed Price Updated: 1:29 PM EST, Dec 15, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	71,242
Open	48.69
Bid (Size)	48.52 (300)
Ask (Size)	48.63 (100)
Prev. Close	48.63
Today's Range	48.51 - 48.96
52wk Range	23.23 - 49.16
Shares Outstanding	32,250,236
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Growth Stock Set to Flourishand 2 Facing Challenges

December 11, 2025

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

1 Mooning Stock with Promising Prospects and 2 Facing Challenges

December 05, 2025

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Via StockStory

Performance

YTD	+69.6%	+69.6%
1 Month	+5.6%	+5.6%
3 Month	+39.1%	+39.1%
6 Month	+63.4%	+63.4%
1 Year	+58.1%	+58.1%

More News

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

November 23, 2025

Via StockStory

Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch

November 17, 2025

Via StockStory

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows High Growth Momentum with Strong Technicals ↗

November 13, 2025

Via Chartmill

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call

November 13, 2025

Via StockStory

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

November 12, 2025

Via StockStory

Collegium to Participate in Upcoming Investor Conferences

November 12, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

2 Momentum Stocks with Exciting Potential and 1 We Find Risky

November 10, 2025

Via StockStory

COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook

November 07, 2025

Via StockStory

Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today

November 06, 2025

Via StockStory

Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗

November 06, 2025

Via Chartmill

Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%

November 06, 2025

Via StockStory

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

November 06, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow

November 04, 2025

Via StockStory

3 Stocks Under $50 That Fall Short

October 31, 2025

Via StockStory

Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment

October 29, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

October 23, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium Pharmaceutical (COLL): Buy, Sell, or Hold Post Q2 Earnings?

October 23, 2025

Via StockStory

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

October 22, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

October 13, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know

October 10, 2025

Via StockStory

1 Russell 2000 Stock to Research Further and 2 We Avoid

September 26, 2025

Via StockStory

Branded Pharmaceuticals Stocks Q2 Highlights: Collegium Pharmaceutical (NASDAQ:COLL)

September 24, 2025

Via StockStory

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?

Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.

What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?

Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?

The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market

What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?

The current price of Collegium Pharmaceutical, Inc. - Common Stock is 48.56

When was Collegium Pharmaceutical, Inc. - Common Stock last traded?

The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 12/15/25 01:29 PM ET

What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?

The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.57B

How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?

Collegium Pharmaceutical, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.